粒子植入演示的.ppt

图像引导下的放射性粒子植入技术; 放射性粒子植入治疗术是根据三维粒子种植计划，通过CT、B超引导下或者手术中将粒子直接种植到肿瘤靶区，放射性粒子永久存留在人体内直接杀伤肿瘤细胞。 ;放射性粒子治疗优点;放射性粒子治疗剂量学优点;生物学优势：持续低剂量率照射 肿瘤细胞周期再分布 肿瘤细胞再修复 肿瘤细胞再增殖 肿瘤细胞内乏氧;适应症;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;禁忌证;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;规范中规定：病历中必需治疗计划或术后剂量验证;临床应用;头颈部肿瘤;理想的腮腺癌治疗结果;现有治疗手段;剂量设置;左腮腺粘液表皮样癌;术中所见;制定治疗计划;粒子植入过程;术后一年;左腮腺肌上皮癌复发;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;术后2个月;植入后半年，PET/CT未见肿瘤征象;粒子植入治疗涎腺癌;恶性肌上皮瘤一;恶性肌上皮瘤二;恶性肌上皮瘤三;恶性肌上皮瘤四;恶性肌上皮瘤五;异常反应;上颌窦癌一;上颌窦癌二 术中;上颌窦癌三;鼻咽癌治疗后残留及复发接近30%。 外照射剂量的提高受到限制， 鼻咽癌复发后的治疗是非常困难的，此时再程放疗有时也不能再进行 组织间粒子放射治疗在放疗后复发的病人挽救治疗中尤为突出。 ;处方剂量140Gy;晚期食道癌覆膜粒子支架植入治疗;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;肺癌及肺转移癌;适应证;术前计划;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0. Copyright 2004-2011 Aspose Pty Ltd.;术前;Evaluation only. Created with Aspose.Slides for .NET 3.5 Client Profile 5.2.0.0